Middle-age Women Treated for DCIS Can Be Healthier Than General Population

Middle-age Women Treated for DCIS Can Be Healthier Than General Population
Women over 50 treated for ductal carcinoma in situ (DCIS) are as likely to be alive 10 years after diagnosis as people who never had this disease, and might even be healthier than the general population, data presented at the recent European Cancer Congress 2017 show. "Ductal carcinoma in situ can be a worrying and confusing diagnosis for many women, especially due to the word 'carcinoma,'  Philip Poortmans, president-elect of ECCO and head of the Radiation Oncology Department at Radboud University Medical Center, said in a press release. DCIS is non-invasive cancerous lesion of the milk ducts, and does not spread. But, as Poortmans also noted, it can progress into a breast cancer that is invasive. Improved screening programs and their use is leading to increasing numbers of women being diagnosed with DCIS, but these findings are reassuring. Essentially, they say that although these patients' risk of dying from breast cancer is higher than in women in general, they have a lower risk of dying from any cause. The team led by Dr. Jelle Wesseling, a breast pathologist at the Netherlands Cancer Institute, studied nearly 10,000 Dutch women who were diagnosed with DCIS between 1989 and 2004. After following the women for an average of 10 years, the researchers found that women diagnosed with DCIS had a 2.5% and 4% risk of dying from breast cancer at 10 and 15 years, respectively, which was slightly higher than that of women not diagnosed with the disease. These death rates, however, were falling over time. And women 50 or older with DCIS were 10% less likely to die of any cause than women in the general population. "It migh
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.